Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-23
Closed -$3.04K 497
2024
Q1
$3.04K Sell
23
-31
-57% -$3.82K ﹤0.01% 112
2023
Q4
$5.89K Sell
54
-410
-88% -$42.6K ﹤0.01% 105
2023
Q3
$53.5K Buy
464
+241
+108% +$26K 0.01% 88
2023
Q2
$25.7K Hold
223
0.01% 119
2023
Q1
$23.7K Buy
223
+222
+22,200% +$24K 0.01% 89
2022
Q4
$212 Sell
1
-199
-100% -$20.3K ﹤0.01% 622
2022
Q3
$17K Sell
200
-145
-42% -$12.9K ﹤0.01% 72
2022
Q2
$31K Buy
+345
New +$30.6K 0.01% 75
2022
Q1
Sell
-456
Closed -$33K 146
2021
Q4
$33K Sell
456
-1
-0.2% -$80 0.01% 70
2021
Q3
$34K Sell
457
-19
-4% -$1.45K 0.01% 63
2021
Q2
$37K Buy
+476
New +$35.4K 0.01% 43
2020
Q4
Sell
-1,812
Closed -$143K 135
2020
Q3
$143K Hold
1,812
0.06% 32
2020
Q2
$134K Hold
1,812
0.05% 35
2020
Q1
$133K Sell
1,812
-210
-10% -$16.5K 0.06% 39
2019
Q4
$175K Buy
+2,022
New +$166K 0.16% 33

Other funds holding MRK

TFO Wealth Partners's MRK Position: Q2 2024 in Review

TFO Wealth Partners sold out of Merck (MRK) in Q2 2024, closing a stake of 23 shares — an estimated $3.04K sold.

TFO Wealth Partners first reported a position in MRK in Q4 2019 and held it in 15 quarters. The position peaked at $175K in Q4 2019. 3,544 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

  • TFO Wealth Partners reported no remaining Merck position as of Q2 2024 after selling out during the quarter.
  • TFO Wealth Partners sold 23 Merck shares in Q2 2024, an estimated $3.04K.
  • TFO Wealth Partners first reported a position in Merck in Q4 2019 and held it in 15 quarters.
  • TFO Wealth Partners's Merck position peaked at $175K in Q4 2019.
  • 3,544 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on TFO Wealth Partners's 13F filing for Q2 2024, filed 15 Aug 2024.